Medifast (MED) Total Liabilities (2010 - 2026)

Medifast's Total Liabilities history runs 17 years deep, the most recent figure standing at $54.4 million for Q1 2026.

• Quarterly Total Liabilities fell 21.27% year-over-year to $54.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (down 21.27% YoY) and the FY2025 annual result came in at $49.1 million, down 33.81% from the prior year.
• Total Liabilities was $54.4 million for Q1 2026 at Medifast, up from $49.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $211.1 million in Q2 2022 and bottomed at $49.1 million in Q4 2025.
• A 5-year average of $111.2 million and a median of $91.8 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 35.58% — and 2025, when it tumbled 39.57%.
• Medifast's Total Liabilities stood at $161.2 million in 2022, then tumbled by 32.72% to $108.4 million in 2023, then slumped by 31.66% to $74.1 million in 2024, then tumbled by 33.81% to $49.1 million in 2025, then gained by 10.83% to $54.4 million in 2026.
• Business Quant data shows MED's Total Liabilities at $54.4 million in Q1 2026, $49.1 million in Q4 2025, and $53.5 million in Q3 2025.